Biomarin Pharmaceutical Inc (BMRN)
80.81
-0.91
(-1.11%)
USD |
NASDAQ |
May 10, 13:12
Biomarin Pharmaceutical Total Assets (Quarterly): 6.873B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.873B |
December 31, 2023 | 6.842B |
September 30, 2023 | 6.758B |
June 30, 2023 | 6.563B |
March 31, 2023 | 6.434B |
December 31, 2022 | 6.375B |
September 30, 2022 | 6.264B |
June 30, 2022 | 6.146B |
March 31, 2022 | 6.063B |
December 31, 2021 | 6.005B |
September 30, 2021 | 5.977B |
June 30, 2021 | 5.898B |
March 31, 2021 | 5.805B |
December 31, 2020 | 5.848B |
September 30, 2020 | 6.158B |
June 30, 2020 | 5.302B |
March 31, 2020 | 4.723B |
December 31, 2019 | 4.690B |
September 30, 2019 | 4.558B |
June 30, 2019 | 4.393B |
March 31, 2019 | 4.435B |
December 31, 2018 | 4.427B |
September 30, 2018 | 4.695B |
June 30, 2018 | 4.625B |
March 31, 2018 | 4.597B |
Date | Value |
---|---|
December 31, 2017 | 4.633B |
September 30, 2017 | 4.581B |
June 30, 2017 | 4.020B |
March 31, 2017 | 3.939B |
December 31, 2016 | 4.024B |
September 30, 2016 | 3.842B |
June 30, 2016 | 3.087B |
March 31, 2016 | 3.667B |
December 31, 2015 | 3.729B |
September 30, 2015 | 3.625B |
June 30, 2015 | 3.649B |
March 31, 2015 | 3.659B |
December 31, 2014 | 2.475B |
September 30, 2014 | 2.440B |
June 30, 2014 | 2.346B |
March 31, 2014 | 2.341B |
December 31, 2013 | 2.244B |
September 30, 2013 | 1.621B |
June 30, 2013 | 1.602B |
March 31, 2013 | 1.598B |
December 31, 2012 | 1.568B |
September 30, 2012 | 1.567B |
June 30, 2012 | 1.533B |
March 31, 2012 | 1.297B |
December 31, 2011 | 1.306B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.393B
Minimum
Jun 2019
6.873B
Maximum
Mar 2024
5.884B
Average
6.034B
Median
Total Assets (Quarterly) Benchmarks
Pfizer Inc | 221.10B |
Eli Lilly and Co | 63.94B |
Merck & Co Inc | 105.85B |
Bristol-Myers Squibb Co | 99.03B |
Moderna Inc | 16.73B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 1.799B |
Shareholders Equity (Quarterly) | 5.074B |
Debt to Equity Ratio | 0.2144 |
Current Ratio | 2.744 |
Net Debt Paydown Yield | -0.01% |